Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies
about
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeMuscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).Jagged-2 enhances immunomodulatory activity in adipose derived mesenchymal stem cellsBrief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositisThe juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesCongenital muscular dystrophy with inflammation: Diagnostic considerations.Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study.Idiopathic inflammatory myopathies-a review.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.Physical exercise as a treatment for adult and juvenile myositis.Modelling disease activity in juvenile dermatomyositis: A Bayesian approach.Treatment of muscle weakness in neuromuscular disorders.Juvenile dermatomyositis: a tertiary center experience.Juvenile polymyositis with unremitting pain and progressive loss of motor and bulbar function on a background of sickle cell disease.Juvenile polymyositis associated with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody in a 13-year-old girl.Muscles in motion: a randomized controlled trial on the feasibility, safety and efficacy of an exercise training programme in children and adolescents with juvenile dermatomyositis.Efficacy of ultrasound elastography in detecting active myositis in children: can it replace MRI?Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activity.Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis.Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.Trajectories of cardiorespiratory fitness in patients with juvenile dermatomyositis.Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.Quantitative muscle ultrasonography in the follow-up of juvenile dermatomyositis.Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody.Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study
P2860
Q33419638-DACDE675-8B71-4AE5-BC8A-CCBA6AB25D6AQ33556620-7D836C1F-6C21-45E0-8561-CDB6122FDCE1Q36100010-E0B35B26-CDA6-4321-982F-A75D36DF6C67Q36619819-28A286A0-AC0B-4143-91FA-4DC27B7DE586Q36842564-3E6A4698-7130-42C6-A980-7C7041BC5162Q37022721-2688D197-4E28-41A0-AF91-C87857512F46Q37167371-BD39EC83-2EB9-4E4C-BBA7-2F083CEAB546Q37388175-B4F4C086-8652-409D-B658-033799F0517AQ37410392-70D760C4-A3AD-4C5E-9321-8E26C0AA646FQ38355216-B8A188D3-B843-4E7B-8693-833FEA5991F4Q38597575-3F702C2B-478D-412D-A47E-419342EFC645Q38690044-0C9BC99D-BD47-494A-B5A0-CE9198ED6C76Q38725766-A7A0724C-0DAE-4B7A-A2C9-9FEC1F986E1EQ38738961-CD8E961F-0569-4755-90FF-5F63AEFF8CCDQ38845507-6DD61958-2CDA-4D0B-A8D4-07C0BA9A4877Q39036962-B22F1A53-5EC5-46B6-AE1A-E3C166B6C816Q39270214-505467A4-7D8F-4F4E-BABD-B8377AA9944EQ40168656-BBC3EBE5-CA3E-49FC-B59F-693AC90809A2Q40739536-4B2B18EE-F16F-4CC0-AF94-69D0C7E74CD0Q41026824-4E681080-D68D-4C12-BD5D-B4479170FE0BQ41687211-1043AB89-9FB2-419D-9311-9CE6137AF3BBQ46134512-B5E4417E-DB8D-4BC1-AA45-DE68C87D2871Q47593445-6A6697C4-70C9-4018-8BA2-2EEEFE769418Q47800428-6AC70D26-7D83-443E-8138-112E323608DDQ51090216-DA22C2B5-8DA2-4AAB-81C6-48591CB2FB04Q54298821-DB5A74F9-0F96-444F-8C7D-A9D8CFB03178Q55311957-E45A275A-7C96-458B-B154-CF30AE5D5EC1Q58778034-B332F667-4BE5-4569-8311-9D23EFEDDEBB
P2860
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Developments in the classifica ...... pathic inflammatory myopathies
@ast
Developments in the classifica ...... pathic inflammatory myopathies
@en
Developments in the classifica ...... pathic inflammatory myopathies
@nl
type
label
Developments in the classifica ...... pathic inflammatory myopathies
@ast
Developments in the classifica ...... pathic inflammatory myopathies
@en
Developments in the classifica ...... pathic inflammatory myopathies
@nl
prefLabel
Developments in the classifica ...... pathic inflammatory myopathies
@ast
Developments in the classifica ...... pathic inflammatory myopathies
@en
Developments in the classifica ...... pathic inflammatory myopathies
@nl
P2860
P3181
P1476
Developments in the classifica ...... pathic inflammatory myopathies
@en
P2093
James D Katz
Olcay Y Jones
P2860
P304
P3181
P356
10.1016/J.RDC.2013.06.001
P407
P577
2013-09-19T00:00:00Z